Effectiveness and cost of integrating a pragmatic pathway for prescribing liraglutide 3.0 mg in obesity services (STRIVE study): study protocol of an open-label, real-world, randomised, controlled trial.
Dimitris PapamargaritisWerd Al-NajimJonathan LimJames CraneMike LeanCarel le RouxBarbara McGowanDonal O'SheaDavid WebbJohn WildingMelanie J DaviesPublished in: BMJ open (2020)
ClinicalTrials.gov-Identifier: NCT03036800.European Clinical Trials Database-Identifier: EudraCT Number 2017-002998-20.
Keyphrases
- study protocol
- clinical trial
- randomized controlled trial
- primary care
- healthcare
- metabolic syndrome
- type diabetes
- open label
- insulin resistance
- systematic review
- mental health
- adverse drug
- weight loss
- weight gain
- physical activity
- double blind
- emergency department
- phase ii
- body mass index
- skeletal muscle
- affordable care act
- health insurance